Cell line · CVCL_0326
Hep 3B2.1-7
Cancer cell line, Homo sapiens. Childhood hepatocellular carcinoma. 156 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. Hep 3B2.1-7. Cell lines, record CVCL_0326. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0326
On this page
Cell line
As Cellosaurus gives it.
- Name
- Hep 3B2.1-7
- Accession
- CVCL_0326
- RRID
- RRID:CVCL_0326
- Synonyms
- Hep 3B2_1-7, Hep 3B 2.1-7, HEP3B217, Hep 3B2, HEP-3B2, HEP3B2, Hep-3B, HEP-3B, Hep 3B, Hep3B, HEP3B
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 8Y
- Category
- Cancer cell line
- Diseases
- Childhood hepatocellular carcinoma (NCIt C7955); Pediatric hepatocellular carcinoma (ORDO Orphanet_33402)
- Derived from
- Liver (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers156
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Morpholino-mediated splice switching of NELFE suppresses hepatocellular carcinoma cell phenotypes in vitro and in vivo. | Mol Ther Nucleic Acids | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A scalable, high-throughput glue perturbation screening platform for molecular glue discovery. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RBM25 Drives Hepatocellular Carcinoma Progression by Stabilizing YAP Through Regulating Oncogenic Splicing-switch of MYPT1. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bioactive Properties of Achillea biserrata M.Bieb. Extracts: Phytochemical Analysis, Antioxidant Activity, Target Enzyme Inhibition, and Cytotoxic Effects. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RNF180 loss stabilizes BCAS4 to enhance PD-L1 expression and immune evasion in hepatocellular carcinoma. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Epigenetic priming and locus-specific demethylation enhance cell-death susceptibility in liver cancer. | Mol Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications. | J Biol Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mechanosensors Collaborate to Regulate DNA Damage Repair in Hepatocellular Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Gene expression adaptation of metastases to their host tissue. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 156
See all 156 papersRelatives19
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | F6D2 | CVCL_B6FG | Cell lines | |
| Derived from it | Hep 3B-Luc | CVCL_C8YA | Cell lines | |
| Derived from it | Hep3B GPC3-KO | CVCL_F6LB | Cell lines | |
| Derived from it | Hep3B-c1 | CVCL_C8Q9 | Cell lines | |
| Derived from it | Hep3BLAP-I | CVCL_DI39 | Cell lines | |
| Derived from it | Hep3BLAP-II | CVCL_DI40 | Cell lines | |
| Derived from it | Hep3BLIP-I | CVCL_DI41 | Cell lines | |
| Derived from it | Hep3BLIP-II | CVCL_DI42 | Cell lines | |
| Derived from it | Hep3b-Cas9-741 | CVCL_XE51 | Cell lines | |
| Derived from it | Hep3b-Cas9-742 | CVCL_XE52 | Cell lines |
1 to 10 of 19
See all 19 relativesCell banks17
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HB-8064 | ATCC | |
| AddexBio | C0015001/45 | Cellosaurus | |
| BCRC | 60434 | BCRC | |
| BCRJ | 0357 | BCRJ | |
| CCTCC | GDC0070 | Cellosaurus | |
| CLS | 305141 | CLS | |
| DSMZ | ACC-93 | DSMZ | |
| ECACC | 86062703 | ECACC | |
| EDITGENE | EDC00381 | EDITGENE | |
| Hysigen | TCH-C195 | Hysigen |
1 to 10 of 17
See all 17 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0326
GET https://conductscience.org/api/cell-lines/v1/CVCL_0326/papers?page=2